个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Multidisciplinary expert consensus on diagnosis and treatment of multiple lung cancers

| 认领 | 导出 | |

文献详情

资源类型：
Pubmed体系：
作者：
Chen Kezhong[1,2] * ; Liu Anwen[3] ; Wang Changli[4] ; Hu Chengping[5] ; Chen Chun[6] ; Yang Fan[1,2] ; Chen Haiquan[7] ; Shen Hongbing[8] ; Zhang Hongtao[9] ; Liu Hongxu[10] ; Xiong Jianping[11] ; Wang Jie[12] ; Zhang Li[13] ; Xu Lin[14] ; Wang Lvhua[15] ; Zhao Mingfang[16] ; Li Qiang[17] ; Song Qibin[18] ; Zhou Qinghua[19] ; Wang Qun[20] ; Ma Shenglin[21] ; Xu Shidong[22] ; Yuan Shuanghu[23] ; Gao Shugeng[24] ; Lu Shun[25] ; Li Weimin[26] ; Mao Weimin[27] ; Liu Xiaoqing[28] ; Dong Xiaorong[29] ; Yang Xuening[30] ; Wu Yilong[31] ; Cheng Ying[32] ; Song Yong[33] ; Huang Yunchao[34] ; Zhang Zhenfa[4] ; Chen Zhiwei[35] ; Ma Zhiyong[36] ; Zielinski Christoph C[37] ; Shyr Yu[38] ; Wang Jun[1,2] ;
机构： [1]Thoracic Oncology Institute, Peking University People’s Hospital, Beijing 100044, China [2]Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Chinese Academy of Medical Sciences, 2021RU002, Peking University People’s Hospital, Beijing 100044, China [3]Department of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, China [4]Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, China [5]Department of Respiratory Medicine, Xiangya Hospital of Central South University, Changsha, China [6]Thoracic Surgery Department, Fujian Medical University Union Hospital, Fuzhou, China [7]Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China [8]Department of Epidemiology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China [9]Soochow University Laboratory of Cancer Molecular Genetics, Suzhou Medical College of Soochow University, Suzhou, Jiangsu 215123, China [10]Department of Thoracic Surgery, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Shenyang 110042, China [11]Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China [12]Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China [13]Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China [14]Department of Thoracic Surgery, Jiangsu Cancer Hospital, Nanjing, China [15]Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China [16]Department of Medical Oncology, The First Hospital of China Medical University, Shenyang 110001, China [17]Department of Respiratory Medicine, Shanghai Dongfang Hospital, Shanghai, China [18]Department of Oncology, Cancer Center, Remin Hospital of Wuhan University, Wuhan, China [19]Lung Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China [20]Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China [21]Department of Oncology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou Cancer Hospital, Cancer Center, Zhejiang University School of Medicine, Hangzhou, China [22]Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China [23]Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital Affiliated with Shandong First Medical University, Jinan, China [24]Thoracic Surgery Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China [25]Department of Medical Oncology, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China [26]Department of Respiratory and Critical Care Medicine, Med-X Center for Manufacturing, Center of Precision Medicine, Precision Medicine Key Laboratory of Sichuan Province, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China [27]Department of Cancer Medicine (Thoracic), Zhejiang Cancer Hospital, Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology (Esophagus, Lung), Hangzhou 310022, China [28]Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China [29]Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China [30]Department of Pulmonary Surgery, Guangdong Lung Cancer Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China [31]Department of Pulmonary Oncology, Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guandong, China [32]Department of Oncology, Jilin Cancer Hospital, Changchun, China [33]Department of Respiratory and Critical Care Medicine, Jinling Hospital, Nanjing, China [34]Department of Thoracic Surgery I, Key Laboratory of Lung Cancer of Yunnan Province, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Cancer Center of Yunnan Province, Kunming, China [35]Department of Medical Oncology, Shanghai Lung Cancer Center, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China [36]Department of Respiratory Medicine, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China [37]Medical Oncology, Central European Cancer Center, Wiener Privatklinik Hospital, Vienna, Austria [38]Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN, USA
出处：
DOI： 10.1016/j.medj.2025.100643
ISSN：

摘要：
The rising incidence of multiple lung cancers (MLCs), encompassing multiple primary lung cancers (MPLCs) and intrapulmonary metastasis (IPM), poses two significant clinical challenges. First, distinguishing between MPLC and IPM remains difficult due to insufficiently accurate criteria and ambiguous integration of genetic testing. Second, standardized therapeutic protocols are still lacking. To address these issues, the Lung Cancer Expert Committee of China Anti-Cancer Association (CACA) assembled a multidisciplinary expert panel spanning thoracic surgery, pulmonary medicine, oncology, radiology, and pathology. Following a comprehensive literature review ending on October 23, 2024, the panel engaged in iterative discussions and conducted two rounds of expert voting, culminating in 25 evidence-based recommendations across five key domains: epidemiology, pre-treatment evaluation, definitive diagnostics, surgical treatment, and non-surgical treatment. This consensus provides clinicians with practical guidance to enhance diagnostic precision and therapeutic decision-making in MLC management while highlighting unmet needs to inform future guideline development.Copyright © 2025. Published by Elsevier Inc.

基金：
National Natural Science Foundation of China (82373416, 82388102, 82450111, and 92259303); the Noncommunicable Chronic Diseases-National Science and Technology Major Project (2023ZD0501900); the CAMS Medical and Health Science and Technology Innovation Project (2021-I2M-5-002); Beijing Natural Science Foundation (L234002 and Z240013); and Peking University People’s Hospital Research and Development Funds (RZG2024-02).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2025]版：
大类 | 1 区 医学
小类 | 1 区 医学：研究与实验
最新[2025]版：
大类 | 1 区 医学
小类 | 1 区 医学：研究与实验
第一作者：
第一作者机构： [1]Thoracic Oncology Institute, Peking University People’s Hospital, Beijing 100044, China [2]Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Chinese Academy of Medical Sciences, 2021RU002, Peking University People’s Hospital, Beijing 100044, China
通讯作者：
通讯机构： [1]Thoracic Oncology Institute, Peking University People’s Hospital, Beijing 100044, China [2]Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Chinese Academy of Medical Sciences, 2021RU002, Peking University People’s Hospital, Beijing 100044, China
推荐引用方式(GB/T 7714)：
Chen Kezhong,Liu Anwen,Wang Changli,et al.Multidisciplinary expert consensus on diagnosis and treatment of multiple lung cancers[J].Med (New York, N.Y.).2025,6(4):100643.doi:10.1016/j.medj.2025.100643.
APA：
Chen Kezhong,Liu Anwen,Wang Changli,Hu Chengping,Chen Chun...&Wang Jun.(2025).Multidisciplinary expert consensus on diagnosis and treatment of multiple lung cancers.Med (New York, N.Y.),6,(4)
MLA：
Chen Kezhong,et al."Multidisciplinary expert consensus on diagnosis and treatment of multiple lung cancers".Med (New York, N.Y.) 6..4(2025):100643

资源点击量：57980 今日访问量：0 总访问量：4797 更新日期：2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号